首页> 外文期刊>Brazilian Journal of Infectious Diseases >Successful treatment of pulmonary Nocardia farcinica infection with linezolid: case report and literature review
【24h】

Successful treatment of pulmonary Nocardia farcinica infection with linezolid: case report and literature review

机译:利奈唑胺成功治疗肺部诺卡氏菌感染的病例报告及文献复习

获取原文
           

摘要

Nocardia infection is rare but potentially fatal. Therapy of Nocardia infection remains difficult. Linezolid, a novel oxazolidinone antibiotic, has proven to be effective, but clinical data are limited. Here we describe a case of a 45-year-old man with pulmonary N. farcinica infection following a liver transplantation. The initial therapy was trimethoprim-sulfamethoxazole, which showed no effect. According to susceptibility test, linezolid was administered with clearly improving the patient's condition. The treatment was stopped for anemia as drug related adverse event, and the therapy lasted for as long as 5 months. At the end of treatment clinical cure was confirmed and anemia reversed after discontinuation of linezolid. We also analyzed the clinical data of previously published reports by literature review, focusing on the efficacy and safety of linezolid treatment for Nocardia infection.
机译:诺卡氏菌感染很少见,但可能致命。诺卡氏菌感染的治疗仍然很困难。利奈唑胺是一种新型的恶唑烷酮抗生素,已被证明是有效的,但临床数据有限。在这里,我们描述了一个肝移植后患有肺部N. farcinica感染的45岁男性的病例。最初的治疗方法是甲氧苄氨嘧啶-磺胺甲基恶唑,未见效果。根据药敏试验,使用利奈唑胺可明显改善患者的病情。由于与药物有关的不良事件而导致的贫血停止了治疗,治疗持续了长达5个月。在治疗结束时确认了临床治愈,并且在停用利奈唑胺后贫血得以逆转。我们还通过文献综述分析了以前发表的报告的临床数据,重点研究了利奈唑胺治疗诺卡氏菌感染的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号